All news

Filter by

12/11/2020

The Cystic Fibrosis Foundation Awards a COVID-19 Study Coordinated by Dr. Antonio Recchiuti
11/27/2020

Prof. Paola Patrignani has recently been appointed as editor of Clinical Pharmacology & Therapeutics.
11/16/2020

The antiplatelet agent Revacept prevents the increase of systemic thromboxane A2
10/26/2020

ECC meets CEU - New focus on the backdoor for calcium ions in skeletal muscle cells
10/21/2020

Targeting Vesicular LGALS3BP by an Antibody-Drug Conjugate as Novel Therapeutic Strategy for Neuroblastoma
09/18/2020

The American Cystic Fibrosis Foundation has granted financial support to the Molecular Medicine Unit of prof. Mario Romano for a research study on resolvins and MRSA infections in cystic fibrosis
09/15/2020

Calcium entry units (CEUs): perspectives in skeletal muscle function and disease.
09/02/2020

A new work about response of cystic fibrosis macrophages to SARS-CoV-2
09/02/2020

A recent publication defines efficacy and protective roles of resolvin D1 on lung Inflammation in cystic fibrosis
08/24/2020

New publication from SPaTT Lab directed by Prof. Paola Patrignani
07/27/2020

A new promising approach to fight breast cancer from the laboratory of Prof. Manuela Iezzi
07/13/2020

A new important work published on Cancer Discovery
07/03/2020

Webinar "Trends & development of biological research & academics in context to COVID-19"
06/12/2020

A lesson from the COVID-19 epidemic
06/12/2020

An intriguing new angle on the COVID-19 related therapy from Stefano Sensi
06/12/2020

HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies
06/11/2020

New publication of Paola Patrignani, PI of SpaTT Lab
06/08/2020

Online new CAST website

Pages